Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pro-Dex Inc. | 11 | 0 | 1 | 0 | €20.40 | - | - |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €44.80 | €46.51 | 3.806% |
| Motus GI Holdings Inc. | 1 | 0 | 0 | 0 | €0.43 | €2.37 | 452.929% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.15 | €2.40 | 107.972% |
| Merck & Co. Inc. | 32 | 1 | 1 | 0 | €107.20 | €125.91 | 17.451% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | €18.32 | €26.64 | 45.451% |
| Verastem Inc. | 14 | 0 | 3 | 0 | €2.26 | €16.16 | 615.102% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €2.53 | €4.62 | 82.668% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €102.48 | €116.25 | 13.434% |
| Cigna Corp. | 24 | 0 | 4 | 0 | €327.20 | €360.98 | 10.324% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 7 | 0 | €448.50 | €450.36 | 0.416% |
| Dynavax Technologies Corp | 4 | 0 | 1 | 0 | €10.18 | €26.95 | 164.862% |
| Edwards Lifesciences Corp. | 32 | 1 | 1 | 0 | €63.30 | €83.40 | 31.761% |
| Patterson Companies Inc. | 8 | 0 | 1 | 0 | €20.40 | €30.34 | 48.712% |
| Cytokinetics Inc. | 30 | 1 | 1 | 0 | €52.00 | €84.53 | 62.557% |
| Halozyme Therapeutics Inc. | 22 | 0 | 4 | 0 | €57.76 | €56.47 | -2.235% |
| Brookdale Sr Lvg | 5 | 1 | 1 | 0 | €6.35 | €8.27 | 30.224% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €183.40 | €215.54 | 17.523% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €106.35 | €151.02 | 42.007% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | €7.91 | €27.83 | 251.668% |
| Codexis Inc. | 7 | 1 | 2 | 0 | €2.62 | €9.62 | 266.452% |
| PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | €31.00 | €41.51 | 33.911% |
| Agios Pharmaceuticals Inc. | 9 | 1 | 1 | 0 | €41.60 | €48.75 | 17.186% |
| Radnet Inc. | 10 | 2 | 0 | 0 | €58.50 | €58.05 | -0.772% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | €66.50 | €84.73 | 27.411% |